Welcome to the e-CCO Library!

P071: Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.B. Hahm1*, J.M. Park2, Y.M. Han2, S. Hong3, K.C. Lee4

Created: Thursday, 21 February 2019, 9:14 AM
P071: Improvement of experimental mouse models in inflammatory bowel diseases using flexible video endoscopic colon evaluation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Gay*1, O. Martin Rodriguez2, A. Daoui2, S. Koch1, P. Saas2, S. Valmary Degano3, S. Perruche2, L. Vuitton1

Created: Friday, 22 February 2019, 9:49 AM
P071: Intestinal CD8+ T cell exhaustion is linked to disease activity in ulcerative colitis
Year: 2022
Source: ECCO'22
Authors: Grigorian, M.(1);Salié, H.(1);Mayer, L.S.(1);Globig, A.M.(1);Hockenjos, B.(1);Krimmel, L.(1);Thimme, R.(1);Bengsch, B.(1);Hasselblatt, P.(1);
Created: Friday, 11 February 2022, 3:52 PM
P071: Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Halder*1, W. Khan1, X. Wang1, S. Kuhns2, H. Sweet2, W. Reinisch1, H. McBride2

Created: Friday, 22 February 2019, 9:41 AM
P071: T-cell, B-cell and monocytic infiltrations of myenteric plexus in IBD
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wiese, J.J.(1)*;Fascì, A.(1);Kühl, A.A.(1);Atreya, R.(2);Patankar, J.(2);Siegmund, B.(1);Prüß, M.S.(1);Schumann, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P071: The mesentery in Crohn's disease displays mesenchymal abnormalities
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Walsh L.*1, Kiernan M.2, Sahebally S.1, Kiely P.2, Waldron D.3, Moloney M.4, Skelly M.4, Hidayat H.3, Faul P.5, O'Leary D.P.3, Lowery A.1, Dunne C.2, Coffey J.C.2

Created: Wednesday, 20 February 2019, 10:36 AM
P072 Evaluation of dosing strategies of anti-TNFα monoclonal antibodies using pharmacokinetic modelling and simulation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Démaris1,2, A.M. Grišić1,2, W. Huisinga3, R. Walter4, C. Kloft1

Created: Thursday, 30 January 2020, 10:12 AM
P0720: Cost-effectiveness of vedolizumab vs. ustekinumab as first-line biologic in treatment sequencing for ulcerative colitis in Canada
Year: 2025
Source: ECCO'25
Authors: Kaox7x7x7 K.E.(1);Zhoux7x7x7 J.Y.(2)*;Macx7x7x7 S.(2);Martinx7x7x7 M.(1);Johnstonx7x7x7 K.(1);Marshallx7x7x7 J.K.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0721: Anti-TNFs have similar safety profile to vedolizumab and ustekinumab as first line biologic treatment in elderly patients with Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Thurmx7x7x7 T.(1)*;Javitsx7x7x7 L.(2);Nachmiasx7x7x7 N.(3);Cohenx7x7x7 N.A.(1);Leibovitzhx7x7x7 H.(1);Hirschx7x7x7 A.(1);Ronx7x7x7 Y.(1);Maharshakx7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0722: Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease: Results From the One-Year SEQUENCE Open-Label Long-Term Extension
Year: 2025
Source: ECCO'25
Authors: Peyrin-Birouletx7x7x7 L.(1)*;Atreya x7x7x7 R.(2);Danesex7x7x7 S.(3);Lindsay x7x7x7 J.O.(4);Chapmanx7x7x7 J.C.(5);Anschutzx7x7x7 T.(6);Huangx7x7x7 X.(7);Zambranox7x7x7 J.(8);Plattx7x7x7 A.(9);Joshi x7x7x7 N.(10);Cross x7x7x7 R.K.(11);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0723: Lengthening ustekinumab treatment intervals from every 8 to every 12 weeks in IBD patients in stable remission: preliminary results of a prospective observational cohort study
Year: 2025
Source: ECCO'25
Authors: Devillersx7x7x7 M.(1)*;Fonsx7x7x7 A.(2);Westx7x7x7 R.(3);Van Der Marelx7x7x7 S.(4);Theeuwenx7x7x7 R.(2);Van Schaikx7x7x7 F.(5);Löwenbergx7x7x7 M.(6);Visschedijkx7x7x7 M.(7);Pierikx7x7x7 M.(8);Mujagicx7x7x7 Z.(8);Duijvesteinx7x7x7 M.(9);Laurannex7x7x7 D.(1);De Vriesx7x7x7 A.(1);Van Der Meulen-de Jongx7x7x7 A.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0724: Endoscopic and radiological outcomes of strictureplasty in patients with small bowel stricturing Crohn's disease
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 X.(1)*;Lix7x7x7 Y.(2);Zhux7x7x7 W.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0725: The fragility of randomized clinical trials in evaluating novel therapies for Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Chenx7x7x7 R.(1)*;Zhengx7x7x7 J.(1);Huangx7x7x7 P.(2);Lix7x7x7 L.(1);Chenx7x7x7 M.(1);Zhangx7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0726: The Moderating Role of Adverse Childhood Experiences in the Relationship between Crohn's Disease Activity and the Development of PTSD Symptoms
Year: 2025
Source: ECCO'25
Authors: Di Vincenzox7x7x7 F.(1)*;Spagnolox7x7x7 G.(2);Vecchionex7x7x7 M.(3);D'Onofriox7x7x7 A.M.(4);Camardesex7x7x7 G.(4);Sanix7x7x7 G.(4);Gasbarrinix7x7x7 A.(5);Cammarotax7x7x7 G.(6);Chieffox7x7x7 D.P.R.(2);Ferraresex7x7x7 D.(2);Scaldaferrix7x7x7 F.(7);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0727: Effectiveness and Safety of ustekinumab in the Treatment of Penetrating Crohn’s Disease: A Prospective Real-World Study
Year: 2025
Source: ECCO'25
Authors: Wux7x7x7 Y.(1)*;Huangx7x7x7 Z.(1);Dengx7x7x7 X.(1);Chaox7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0728: Interventions for ocular extraintestinal manifestations in inflammatory bowel disease: an umbrella review of systematic reviews
Year: 2025
Source: ECCO'25
Authors: Estevinhox7x7x7 M.M.(1)*;Solitanox7x7x7 V.(2);Magrox7x7x7 F.(3);Yuanx7x7x7 Y.(2);Jairathx7x7x7 V.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0729: Comparative clinical outcomes of advanced therapy in bio-naïve versus bio-experienced patients hospitalized with Acute Severe Ulcerative Colitis: A retrospective cohort study
Year: 2025
Source: ECCO'25
Authors: Hwangx7x7x7 S.W.(1x7x7x72)*;Kimx7x7x7 S.(1);Leex7x7x7 C.H.(1);Kimx7x7x7 J.W.(1);Kimx7x7x7 M.K.(1);Leex7x7x7 S.(1);Hongx7x7x7 S.W.(1);Parkx7x7x7 S.H.(1x7x7x72);Yangx7x7x7 D.H.(1);Yex7x7x7 B.D.(1x7x7x72);Byeonx7x7x7 J.S.(1);Myungx7x7x7 S.J.(1);Yangx7x7x7 S.K.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P072: : Circadian misalignment by simulated night shifts decreases colonoid barrier integrity in Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Swanson, G.(1)*;Shaikh, M.(1);Keshavarzian, A.(1);Scheer, F.(2);
Created: Friday, 14 July 2023, 10:48 AM
P072: Melanocortin MC3 and MC5 receptors expression is different according to colonic disease activity in Crohn’s Disease and Ulcerative Colitis biopsies: results from an immunohistochemical observational study.
Year: 2022
Source: ECCO'22
Authors: GravinaMD, A.G.(1);Panarese, I.(2);Trotta, M.C.(3);D'Amico, M.(3);Pellegrino, R.(1);Ferraraccio, F.(2);Galdiero, M.(3);Alfano, R.(4);Loguercio, C.(1);Romano, M.(1);Grieco, P.(5);Federico, A.(1);
Created: Friday, 11 February 2022, 3:52 PM